Cargando…

Correction: Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374716/ https://www.ncbi.nlm.nih.gov/pubmed/25811784 http://dx.doi.org/10.1371/journal.pone.0121162

Ejemplares similares

Challenges in Developing a Validated Biomarker for Angiogenesis Inhibitors: The Motesanib Experience
por: Bass, Michael B., et al.
Publicado: (2014)

Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors
por: Caenepeel, Sean, et al.
Publicado: (2010)

Ab-initio and Conformational Analysis of a Potent VEGFR-2 Inhibitor: A Case Study on Motesanib
por: Ebadi, Ahmad, et al.
Publicado: (2014)

Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours
por: Price, T J, et al.
Publicado: (2008)

Safety and Pharmacokinetics of Motesanib in Combination with Panitumumab and Gemcitabine-Cisplatin in Patients with Advanced Cancer
por: Burris, Howard, et al.
Publicado: (2011)

Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors
por: Benjamin, Robert S., et al.
Publicado: (2010)

Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
por: De Boer, Richard H., et al.
Publicado: (2012)

Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b study
por: Kotasek, Dusan, et al.
Publicado: (2011)

A phase 1b, open-label study of trebananib plus bevacizumab or motesanib in patients with solid tumours
por: Hong, David S., et al.
Publicado: (2014)

Correction: Temporal-Spatial Correlation between Angiogenesis and Corticogenesis in the Developing Chick Optic Tectum
Publicado: (2015)

Phase II study of motesanib in Japanese patients with advanced gastrointestinal stromal tumors with prior exposure to imatinib mesylate
por: Sawaki, Akira, et al.
Publicado: (2009)

Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
por: Murukesh, N, et al.
Publicado: (2010)

Correction: Correlating Global Gene Regulation to Angiogenesis in the Developing Chick Extra-Embryonic Vascular System
por: Javerzat, Sophie, et al.
Publicado: (2010)

Correction: Identification and validation of early genetic biomarkers for apple replant disease
por: Rohr, Annmarie-Deetja, et al.
Publicado: (2022)

Correction: Tumor Angiogenesis and Vascular Patterning: A Mathematical Model
por: Travasso, Rui D. M., et al.
Publicado: (2011)

Correction: Tumor Angiogenesis and Vascular Patterning: A Mathematical Model
por: Travasso, Rui D. M., et al.
Publicado: (2016)

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor
por: Chung, Suyoun, et al.
Publicado: (2020)

The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors
por: Rosen, Lee S, et al.
Publicado: (2013)

A case report of motesanib-induced biliary sludge formation causing obstructive cholangitis with acute pancreatitis treated by endoscopic sphincterotomy
por: Song, Jay, et al.
Publicado: (2016)

Correction: The Force at the Tip - Modelling Tension and Proliferation in Sprouting Angiogenesis
Publicado: (2015)

Correction: The development and validation of the Videogaming Motives Questionnaire (VMQ)
por: López-Fernández, Francisco J., et al.
Publicado: (2022)

Correction: De Novo Peptide Design and Experimental Validation of Histone Methyltransferase Inhibitors
Publicado: (2014)

Correction: Predictive biomarkers for disease sensitivity in lymphoma – the holy grail for HDAC inhibitors?
por: Eyre, Toby A.
Publicado: (2019)

Antitumor activity of motesanib alone and in combination with cisplatin or docetaxel in multiple human non–small-cell lung cancer xenograft models
por: Coxon, Angela, et al.
Publicado: (2012)

Correction: Choroid Sprouting Assay: An Ex Vivo Model of Microvascular Angiogenesis
por: Shao, Zhuo, et al.
Publicado: (2013)

Correction: Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort study
Publicado: (2020)

Correction: Modulation of Host Angiogenesis as a Microbial Survival Strategy and Therapeutic Target
por: Osherov, Nir, et al.
Publicado: (2016)

Correction: A Challenge for the Development of Malaria Vaccines: Polymorphic Target Antigens
por: Sutherland, Colin
Publicado: (2007)

Author Correction: Development and large-scale validation of the Watch Walk wrist-worn digital gait biomarkers
por: Chan, Lloyd L. Y., et al.
Publicado: (2023)

Correction: HP1β Is a Biomarker for Breast Cancer Prognosis and PARP Inhibitor Therapy
por: Lee, Young-Ho, et al.
Publicado: (2015)

Correction: Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies
por: Alinezhad, Saeid, et al.
Publicado: (2016)

Correction: Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma
por: Ma, Heng, et al.
Publicado: (2022)

Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease
por: Mijuskovic, Martina, et al.
Publicado: (2019)

Correction: PSF functions as a repressor of hypoxia-induced angiogenesis by promoting mitochondrial function
por: Dong, Lijie, et al.
Publicado: (2023)

Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis
por: Crowson, Cynthia S., et al.
Publicado: (2017)

Correction: The Mentalized Affectivity Scale (MAS): Development and validation of the Italian version
por: Rinaldi, Teresa, et al.
Publicado: (2021)

Correction: Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis
Publicado: (2014)

Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study
por: Liu, Xinyang, et al.
Publicado: (2018)

Correction: Identification and Validation of Protein Biomarkers of Response to Neoadjuvant Platinum Chemotherapy in Muscle Invasive Urothelial Carcinoma
por: Baras, Alexander S., et al.
Publicado: (2015)

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers
por: Winter, Jordan M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n6f1frbmpd9t218d47m49pu4qk